MARKET

OCUTF

OCUTF

Ocumension Thera
OTCPK
--
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
--
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
--
52 WEEK LOW
--
MARKET CAP
--
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
1D
No Data
About OCUTF
Ocumension Therapeutics is a company primarily engaged in the research, development and commercialization of ophthalmic pharmaceuticals. The products primarily include OT-401 Yutiq fluocinolone intravitreal implant, OT-702 Boyoujing aflibercept intravitreous injection, OT-402 Visudyne, OT- 204 Ou Qin sodium hyaluronate eye drops and OT-305 Betoptic S betaxolol hydrochloride and others. The products are used to treat various anterior and posterior segment eye diseases, such as uveitis, fundus diseases, refractive correction, dry eye disease (DED), glaucoma and conjunctivitis. The Company primarily operates its business in the domestic market.

Webull offers Ocumension Therapeutics stock information, including OTCPK: OCUTF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCUTF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCUTF stock methods without spending real money on the virtual paper trading platform.